4.8 Article

Using Gold Nanoparticles To Disrupt the Tumor Microenvironment: An Emerging Therapeutic Strategy

Journal

ACS NANO
Volume 10, Issue 12, Pages 10631-10635

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsnano.6b07673

Keywords

-

Funding

  1. National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [R35GM119659]
  2. American Cancer Society [IRG 14-251-07-IRG]
  3. Department of Defense through a National Defense Science and Engineering Graduate Fellowship

Ask authors/readers for more resources

Gold nanoparticles have received much attention recently as carriers for anticancer drugs and therapeutic oligonucleotides, but little research has investigated their potential to act as stand-alone therapeutics. Previous studies interrogating their short- and long-term systemic toxicity have found that although gold nano particles accumulate within and clear slowly from the liver and spleen, they do not appear to exert toxic effects in these organs. Interestingly, gold nanoparticles innately exhibit the ability to modulate the tumor microenvironment specifically by interfering with crosstalk between tumor cells and stromal cells. In this issue of ACS Nano, Mukherjee and colleagues demonstrate that bare gold nanoparticles can disturb crosstalk between pancreatic stellate cells and pancreatic cancer cells by modulating the cellular secretome to reduce the.growth of desmoplastic tissue and inhibit tumor growth. In this Perspective, we highlight opportunities for anticancer targeting within the tumor microenvironment and discuss gold nanoparticles as potential mediators of microenvironment-targeted therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Nanoscience & Nanotechnology

Membrane-wrapped nanoparticles for photothermal cancer therapy

Sara B. Aboeleneen, Mackenzie A. Scully, Jenna C. Harris, Eric H. Sterin, Emily S. Day

Summary: Cancer is a global health problem and conventional treatments are not satisfactory. Nanoparticle-mediated photothermal therapy has immense potential as a treatment for solid-tumor cancers. By camouflaging with cell membranes, light-responsive nanoparticles can play a unique role in cancer treatment and improve treatment outcomes.

NANO CONVERGENCE (2022)

Article Materials Science, Biomaterials

Membrane-Wrapped Nanoparticles for Enhanced Chemotherapy of Acute Myeloid Leukemia

Jenna C. Harris, Eric H. Sterin, Emily S. Day

Summary: This study reports the development of a biomimetic membrane-wrapped nanoparticle platform for targeted chemotherapy of acute myeloid leukemia (AML). The system showed efficient and targeted delivery of the chemotherapeutic drug doxorubicin (DOX), inducing apoptosis in AML cells. These findings suggest that this drug delivery system has great potential for future development in treating AML and other blood cancers.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2022)

Article Chemistry, Multidisciplinary

Isocorrole-Loaded Polymer Nanoparticles for Photothermal Therapy under 980 nm Light Excitation

Maximilian R. J. Marek, Trong-Nhan Pham, Jianxin Wang, Qiuqi Cai, Glenn P. A. Yap, Emily S. Day, Joel Rosenthal

Summary: Photothermal therapy is a promising treatment option for various diseases. Researchers have developed new nanomaterials that can efficiently convert light into heat in the 850-1000 nm wavelength range, allowing for effective photothermal therapy. These materials provide a new platform for activating photothermal therapy.

ACS OMEGA (2022)

Article Multidisciplinary Sciences

Ionizable lipid nanoparticles deliver mRNA to pancreatic ? cells via macrophage-mediated gene transfer

Jilian R. Melamed, Saigopalakrishna S. Yerneni, Mariah L. Arral, Samuel T. LoPresti, Namit Chaudhary, Anuradha Sehrawat, Hiromi Muramatsu, Mohamad-Gabriel Alameh, Norbert Pardi, Drew Weissman, George K. Gittes, Kathryn A. Whitehead

Summary: Systemic delivery of mRNA to organs outside the liver, spleen, and lungs is difficult. This study presents a novel strategy using lipid nanoparticles to deliver mRNA specifically to the pancreas. Intraperitoneal administration of lipid nanoparticles containing cationic helper lipids results in robust and specific protein expression in the pancreas, with a majority occurring in insulin-producing beta cells. The delivery of pancreatic mRNA is found to be dependent on horizontal gene transfer by peritoneal macrophage exosome secretion. This strategy holds potential for gene therapies targeting pancreatic diseases such as diabetes and cancer.

SCIENCE ADVANCES (2023)

Article Biotechnology & Applied Microbiology

Megakaryocyte membrane-wrapped nanoparticles for targeted cargo delivery to hematopoietic stem and progenitor cells

Samik Das, Jenna C. Harris, Erica J. Winter, Chen-Yuan Kao, Emily S. Day, Eleftherios Terry Papoutsakis

Summary: Hematopoietic stem and progenitor cells (HSPCs) are difficult to target and transfect using existing viral vector-based delivery methods. This study demonstrates the potential of using megakaryocyte (Mk) membranes and megakaryoblastic cell membranes to wrap around poly(lactic-co-glycolic acid) (PLGA) nanoparticles, creating MkNPs and CHNPs, respectively, for targeted delivery to HSPCs. These nanoparticle formulations show promising results in vitro and in vivo, suggesting that they can be effective vehicles for gene therapy in HSPCs.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2023)

Article Nanoscience & Nanotechnology

E-Selectin Targeted Gold Nanoshells to Inhibit Breast Cancer Cell Binding to Lung Endothelial Cells

Z. Fereshteh, M. N. Dang, C. Wenck, E. S. Day, J. H. Slater

Summary: This study investigated the efficacy of inhibiting cancer cell binding to human lung microvascular endothelial cells (HMVEC-Ls) via antibody blocking of E-selectin using antibody-functionalized gold nanoshells (NS). The results demonstrated that E-selectin-targeted NS reduced the binding of MDA-MB-231 cancer cells to HMVEC-Ls by up to 41%, suggesting the potential of these conjugates in inhibiting cancer cell extravasation during metastasis.

ACS APPLIED NANO MATERIALS (2023)

Article Oncology

Combination cancer imaging and phototherapy mediated by membrane-wrapped nanoparticles

Sara B. Aboeleneen, Mackenzie A. Scully, George C. Kramarenko, Emily S. Day

Summary: Cancer is a devastating health problem and current treatment options are inadequate. Nanoparticle-mediated photothermal therapy is a promising minimally invasive treatment for solid-tumor cancers. Cell-derived membrane coatings have emerged as a potential method to improve the tumor-specific delivery of nanoparticles, enhancing the effectiveness of the therapy. Dual-functional membrane-wrapped nanoparticles are also being explored for tumor imaging and ensuring sufficient nanoparticle accumulation in the tumor.

INTERNATIONAL JOURNAL OF HYPERTHERMIA (2023)

Article Medicine, Research & Experimental

Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast Cancer

Mackenzie A. A. Scully, Dana E. E. Wilkins, Megan N. N. Dang, Elise C. C. Hoover, Sara B. B. Aboeleneen, Emily S. S. Day

Summary: Overexpression of B-cell lymphoma 2 (Bcl-2) is linked to poor prognosis in triple-negative breast cancer (TNBC), but current Bcl-2 inhibitors have limited success against solid tumors. In this study, Bcl-2 inhibitor ABT-737 was loaded into poly(lactic-co-glycolic acid) (PLGA) nanoparticles coated with cancer cell membranes, which increased targeting of TNBC cells and improved accumulation in tumors compared to regular PLGA nanoparticles. The cancer cell membrane-wrapped PLGA nanoparticles induced higher levels of apoptosis in TNBC cells in vitro and showed increased anticancer effects in a metastasis model. The specific targeting provided by the TNBC cell membrane coating also reduced off-target adverse effects. Further development of drug-loaded biomimetic nanoparticles may be a promising approach for treating TNBC.

MOLECULAR PHARMACEUTICS (2023)

Article Instruments & Instrumentation

Delivery and short-term maternal and fetal safety of vaginally administered PEG-PLGA nanoparticles

N'Dea S. Irvin-Choy, Katherine M. Nelson, Jason P. Gleghorn, Emily S. Day

Summary: Women with preexisting conditions during pregnancy face challenges in maintaining the safety of the developing fetus and their own health. This study explores the potential use of nanoparticle-based therapies delivered vaginally in pregnant mice, demonstrating their distribution to the reproductive organs without impacting maternal or fetal weight. The findings encourage further investigation into vaginally delivered nanoparticle therapies for vaginal conditions during pregnancy.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

Review Materials Science, Biomaterials

Membrane-wrapped nanoparticles for nucleic acid delivery

Mackenzie A. Scully, Eric H. Sterin, Emily S. Day

Summary: There is a need for carriers that can deliver nucleic acids (NAs) to cancer cells and tumors for gene regulation and disease management. Membrane-wrapped nanoparticles (NPs) can overcome challenges presented by NAs' negative charge, hydrophilicity, and large size and enhance their circulation and accumulation. This review discusses the role of membrane-wrapped NPs as NA delivery vehicles and their advancements in cancer gene regulation. This technology has great potential as a future clinical tool for treating cancer and genetic diseases.

BIOMATERIALS SCIENCE (2022)

Meeting Abstract Biotechnology & Applied Microbiology

Development of Antibody and siRNA Nanocarriers to Target Wnt Signaling in Triple-Negative Breast Cancer

Megan N. Dang, Sejal Suri, Kejian Li, Carolina Gomez Casas, Gianna Stigliano, Mackenzie A. Scully, Elise C. Hoover, Sara Aboeleneen, Emily S. Day

MOLECULAR THERAPY (2022)

Meeting Abstract Obstetrics & Gynecology

Safety of Vaginally Delivered PEG-PLGA Nanoparticles for Local Drug Delivery During Pregnancy

Katherine M. Nelson, N'Dea Irvin-Choy, Emily S. Day, Jason P. Gleghorn

REPRODUCTIVE SCIENCES (2022)

Meeting Abstract Biotechnology & Applied Microbiology

Photoresponsive miR-34a/Nanoshell Conjugates Enable Light-Triggered Gene Regulation to Impair the Function of Triple-Negative Breast Cancer Cells

Megan N. Dang, Carolina Gomez Casas, Emily S. Day

MOLECULAR THERAPY (2021)

Meeting Abstract Biotechnology & Applied Microbiology

Enabling Targeted Cargo Delivery to Hematopoietic Stem and Progenitor Cells with Biomimetic Nanoparticles

Jenna C. Harris, Samik Das, E. Terry Papoutsakis, Emily S. Day

MOLECULAR THERAPY (2021)

Review Engineering, Biomedical

Biomimetic Nanoparticles for the Treatment of Hematologic Malignancies

Emily H. Powsner, Jenna C. Harris, Emily S. Day

Summary: Hematologic malignancies, derived from abnormal hematopoietic stem cells, are often treated with chemotherapy and stem cell transplants, which have detrimental side effects. Researchers are exploring the use of biomimetic nanotherapeutic to treat these cancers, showing promising results in delivering therapeutic cargo to diseased cells.

ADVANCED NANOBIOMED RESEARCH (2021)

No Data Available